Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Bristol Myers Squibb Continues Its Legacy with 93-Year Dividend Streak

December 14, 2024
Bristol Myers Squibb (BMY), a leading pharmaceutical company, has extended its impressive 93-year dividend streak with a 16th consecutive annual increase. This announcement comes as a reflection of the company's commitment to providing consistent returns to its shareholders.

Bristol Myers Squibb has been a top socially responsible dividend stock, with a yield of 4%. The company has prioritized sustainable and responsible business practices, making it an attractive choice for investors seeking both financial growth and social impact.

In addition to its impressive dividend history, Bristol Myers Squibb has been making waves in the healthcare industry. The company's latest appointment of Tim Power as the Head of Investor Relations at Biogen showcases its determination to strengthen investor relations and communicate effectively with stakeholders.

With a solid track record and a focus on long-term growth, Bristol Myers Squibb is positioned as a great value stock. Investors looking to capitalize on the company's success should consider consulting professionals from Stocks Prognosis for an expert forecast of its future stock movement.

As Bristol Myers Squibb continues to make a positive impact in the pharmaceutical industry, its dedication to innovation, shareholder value, and responsible business practices makes it an attractive choice for long-term investors.
If you want to leave a comment, then you need Login or Register





Other data for BMY

Related data

BMYJuly 31, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.1% Profit Achieved  ~1 min.

On April 16, 2025, QuantWave issued a short forecast signal for BRISTOL-MYERS SQUIBB COMPANY with a price of 48.72 $. Fast forward to July 31, 2025, the target price of 43....


BMYJuly 31, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Forecast Price Target with 10.86% Profit  ~1 min.

QuantWave, an automated forecasting platform, recently achieved a milestone in its prediction accuracy with the successful forecast of BRISTOL-MYERS SQUIBB COMPANY's stock movement....


BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....


BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....


BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success  ~2 min.

On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit  ~1 min.

On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit  ~1 min.

On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35....


ABTDecember 1, 2024Abbott Laboratories: A Leading Pharmaceutical Company in the Hands of Institutional Shareholders  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company traded on the NYSE under the ticker symbol ABT, is currently experiencing significant control from institutional shareholders....


BMYDecember 31, 2024Bristol-Myers Squibb Strengthens Investor Confidence with Increased Dividend Payout  ~1 min.

Bristol-Myers Squibb, a renowned pharmaceutical company listed on the NYSE as BMY, has announced a significant increase in its dividend payout compared to the previous year....


AZNFebruary 2, 2025Shareholders of AstraZeneca PLC Should Contact Levi Korsinsky Before February 21 2025 to Discuss Your Rights  ~2 min.

It has come to light that shareholders of AstraZeneca PLC (AZN) are urged to contact Levi Korsinsky, a renowned law firm specializing in securities litigation, before February 21, 2025, to discuss their rights. AstraZeneca PLC, a global pharmaceutical company, has been facing potential legal implications due to recent developments in the industry. Levi Korsinsky is currently investigating possible...


PFENovember 16, 2024Investors Show Interest in Pfizer Inc. PFE as Company Announces Strategic Vision at Healthcare Conference  ~1 min.

Pfizer Inc. (NYSE:PFE) has attracted the attention of investors as the pharmaceutical giant reveals its strategic vision at the Jefferies London Healthcare Conference....


UNHJanuary 1, 2025UnitedHealth Group Incorporated: A Promising Investment Opportunity  ~2 min.

UnitedHealth Group Incorporated (UNH) has been making significant strides in the healthcare industry, positioning itself as a leader in providing innovative healthcare solutions....